Form D · Biotechnology
Pluton Biosciences, Inc.
St. Louis, MO · CIK 0001759355
Offering snapshot reported Jun 2, 2023 · SEC filing
- Reported sold
- $17.6M Offering amount: $17.6M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $75K Reported outside-investor minimum
- First sale
- Feb 24, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2023 | Initial | $17,579,071 | No comparison | 12 | SEC filing |
| Oct 1, 2021 | Initial | $6,682,968 | No comparison | 38 | SEC filing |
| Jan 2, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483201
Source: Form D, filed Jun 2, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
OCEANSOUND PARTNERS CO-INVEST II, LP - SERIES C
Investment adviser: OCEANSOUND PARTNERS, LP
- Gross asset value
- $105M
- Beneficial owners
- 18
- ADV minimum commitment
- $2M
Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
RSM US LLP
PCAOB 49
J.P. MORGAN SECURITIES LLC
SEC 8-35008
Filing source
Form ADV 2083311 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-5795444451
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elizabeth Gallegos | Director, Executive |
| Michael Gillespie | Director |
| Barry Goldman | Director, Executive |
| Neal Gutterson | Director |
| Charles Lin | Director |
| Clay Mitchell | Director |
| Glendon Schuster | Director |
| Wesley Selke | Director |
| Steven Slater | Director, Executive |
| Gerald Steiner | Director |
| Charlie Walch | Director, Executive |
| Charles Walch | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:St. Louis, MO, 63146